Active	Status	Sponsor type	Region	Phase	Filter
21 Active 53 Inactive 74 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hordinsky, Maria
SCALP1, NCT05910450: A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss	Recruiting	3	726	US, RoW	Clascoterone 5% solution, CB-03-01 5% solution, Vehicle solution, Vehicle	Cassiopea SpA, Ergomed PLC, Pharmapace Inc, Canfield Scientific Inc., ICON Clinical Research	Alopecia, Androgenetic	10/24	04/25
BRAVE-AA-PEDS, NCT05723198: A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata	Recruiting	3	595	Europe, Canada, Japan, US, RoW	Baricitinib, LY3009104, Placebo	Eli Lilly and Company	Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases, Skin Diseases, Pathological Conditions, Anatomical	09/24	08/29
BRAVE-AA1, NCT03570749: A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata Efficacy and safety data from BRAVE-AA1 trial in adults with severe alopecia areata Apr 2021 - Apr 2021: Efficacy and safety data from BRAVE-AA1 trial in adults with severe alopecia areata From BRAVE-AA1 trial for alopecia areata Oct 2020 - Oct 2020: From BRAVE-AA1 trial for alopecia areata	Active, not recruiting	2/3	824	Japan, US, RoW	Baricitinib, LY3009104, Placebo	Eli Lilly and Company, Incyte Corporation	Alopecia Areata	02/21	01/25
TARGET-DERM, NCT03661866: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC	Recruiting	N/A	15000	Europe, Canada, US		Target PharmaSolutions, Inc.	Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria	12/50	12/50
Hatsukami, Dorothy
No trials found
Hatsukami, Dorohty
No trials found